PMC:7029759 / 33391-33547 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7029759","sourcedb":"PMC","sourceid":"7029759","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7029759","text":"or neutralizing antibodies in MERS 73. It’s unclear what clinical significance this would have, and to what extent this would happen in vivo. Ultimately, cl","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"877","span":{"begin":30,"end":34},"obj":"Disease"}],"attributes":[{"id":"A877","pred":"tao:has_database_id","subj":"877","obj":"MESH:D018352"},{"subj":"877","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T407","span":{"begin":16,"end":26},"obj":"GO:0042571"},{"id":"T406","span":{"begin":30,"end":34},"obj":"SP_9"}],"attributes":[{"subj":"T407","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T406","pred":"source","obj":"LitCovid-PMC-OGER-BB"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T207","span":{"begin":39,"end":141},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T207","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#a793ec","default":true},{"id":"LitCovid-PMC-OGER-BB","color":"#98ec93"},{"id":"LitCovid-sentences","color":"#ec93b2"}]}]}}